Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Location status: Recruiting
NCT Number: NCT06597838
Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China, and validated it across five independent, geographically distinct, different tiered hospitals.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Beijing, Beijing Municipality, 100034, China
Location status: Recruiting
Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China using the machine learning technique, and then validated the performance of the prediction model across five independent, geographically distinct, different tiered hospitals in China.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, varied from one to three years in different validation cohorts.
Evaluated using AUC
Contact information is provided by the study sponsor or research team.
Peking University First Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07101770
Anemia, Anemia, Aplastic
Beijing, China
View Trial DetailsNCT06978348
Artificial Intelligence, Ischemic Cerebrovascular Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06451887
Brain Diseases, Brain Edema
Hangzhou, Zhejiang, China
View Trial DetailsNCT06415630
Nomogram, Postoperative Reintubation
Wuhan, Hubei, China
View Trial Details